Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014

BACKGROUND: Human papillomavirus (HPV) vaccine was recommended in 2006 for routine vaccination of US females aged 11–12 years. Most vaccine used through 2014 was quadrivalent vaccine (4vHPV), which prevents HPV-6, -11, -16, and -18 infection. To evaluate vaccine impact, we measured HPV prevalence in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Infect Dis
Hlavní autoři: Oliver, Sara E., Unger, Elizabeth R., Lewis, Rayleen, McDaniel, Darius, Gargano, Julia W., Steinau, Martin, Markowitz, Lauri E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740482/
https://ncbi.nlm.nih.gov/pubmed/28931217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix244
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky